SL-164
 | |
| Systematic (IUPAC) name | |
|---|---|
|
5-chloro-3-(4-chloro-2-methylphenyl)-2-methylquinazolin-4-one | |
| Identifiers | |
| CAS Number | 3476-88-8 |
| ATC code | None |
| PubChem | CID 63386 |
| Chemical data | |
| Formula | C16H12Cl2N2O |
| Molar mass | 319.185 |
| |
SL-164 is an analogue of methaqualone developed in the late 1960s by a team at Sumitomo.[1] SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use.[2]
References
- ↑ US Patent 3651230 COMPOSITIONS AND METHODS FOR TRANQUILIZING WITH SUBSTITUTED 3-PHENYL-4-QUINAZOLINONE DERIVATIVES
- ↑ Saito, C.; Sakai, S.; Yukawa, Y.; Yamamoto, H.; Takagi, H. (1969). "Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4H)-quinazolinone (SL-164)". Arzneimittel-Forschung 19 (12): 1945–1949. PMID 4985336.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, August 28, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.